ADAR2 Antibodies

Santa Cruz Biotechnology provides a broad selection of ADAR2 monoclonal antibodies for investigating ADAR2 protein function. ADAR2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ADAR2, or Adenosine Deaminase Acting on RNA 2, catalyzes the editing of RNA molecules, significantly impacting gene expression regulation and nervous system development. ADAR2 plays an essential role in neuronal function and has been linked to several neurological disorders. RNA editing by ADAR2 modifies specific adenosine residues to inosine, affecting protein coding sequences and splicing patterns. Studying ADAR2 activity provides valuable insights into RNA modification mechanisms and their biological significance. Research focusing on ADAR2 continues to reveal new aspects of RNA biology and its influence on cellular processes. ADAR2 investigation has become increasingly important in understanding neurodegenerative diseases and potential therapeutic approaches. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of ADAR2's role in health and disease.